Bradley Bailey

Bradley Bailey is an accomplished executive with extensive experience in the pharmaceutical and biotechnology industries. Currently serving as Executive Vice President and Chief Commercial Officer at Genmab since July 2020, Bradley previously held roles at Ipsen, including Senior Vice President and Franchise Head for Oncology, and also contributed as Vice President at AVEO Oncology. Earlier in Bradley's career, significant positions included Head of the US Immunology Business Unit at UCB and leadership in Sales and Marketing at Stryker. Bradley holds a Bachelor of Science in Business Administration with a focus on Marketing, Management, and Operations from Clemson University, and completed an Executive Course in Finance at Harvard Business School.